via The Scientist RSS https://ift.tt/QHAdnNB The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug. https://ift.tt/2nGB01f May 20, 2022 at 08:00PM